Press release
Surgical Site Infections Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Destiny Pharma plc, MinaPharm Pharma, Duke Clinical Researc
The Surgical Site Infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
"Surgical Site Infections Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Surgical Site Infections Market.
Some of the key takeaways from the Surgical Site Infections Pipeline Report:
*
Companies across the globe are diligently working toward developing novel Surgical Site Infections treatment therapies with a considerable amount of success over the years.
*
Surgical Site Infections companies working in the treatment market are Destiny Pharma plc, MinaPharm Pharma, Duke Clinical Research, Zurex Pharma, Inc., Merck Sharp & Dohme LLC, PolyPid Ltd., Durata Therapeutics, Lindenhofgruppe AG, Veristat, Inc, and others, are developing therapies for the Surgical Site Infections treatment
*
Emerging Surgical Site Infections therapies in the different phases of clinical trials are- Ciprodiazole, DFA-02, ZuraPrep, Ertapenem, XF-73, D-PLEX, Dalbavancin, BACTROBAN Registered Nasal ong, E-101, and others are expected to have a significant impact on the Surgical Site Infections market in the coming years.
*
In August 2025, Mayo Clinic researchers created an artificial intelligence (AI) system that can accurately identify surgical site infections (SSIs) from patient-submitted postoperative wound images. Published in Annals of Surgery, this advancement marks significant progress in remote patient monitoring and infection prevention.
*
In June 2025, PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharmaceutical company focused on enhancing surgical outcomes, announced positive topline results from its pivotal SHIELD II Phase 3 trial of D-PLEX100. The therapy, designed to prevent surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions, has also received Fast Track designation from the FDA.
Surgical Site Infections Overview
Surgical Site Infections are infections that occur at the site of a surgical incision or in the surrounding tissue following a surgical procedure. These infections can range from superficial infections involving the skin and subcutaneous tissue to more severe infections affecting deeper layers of tissue, such as muscles and organs.
Get a Free Sample PDF Report to know more about Surgical Site Infections Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/surgical-site-infections-ssi-pipeline-insight [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Surgical Site Infections Drugs Under Different Phases of Clinical Development Include:
*
XF-73: Destiny Pharma plc
*
Ciprodiazole: MinaPharm Pharma
*
DFA-02: Duke Clinical Research
*
ZuraPrep: Zurex Pharma, Inc.
*
Ertapenem: Merck Sharp & Dohme LLC
*
D-PLEX: PolyPid Ltd.
*
Dalbavancin: Durata Therapeutics
*
BACTROBAN Registered Nasal ong: Lindenhofgruppe AG
*
E-101: Veristat, Inc
Surgical Site Infections Route of Administration
Surgical Site Infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Inhalation
*
Inhalation/Intravenous/Oral
*
Intranasal
*
Intravenous
*
Intravenous/ Subcutaneous
*
NA
*
Oral
*
Oral/intranasal/subcutaneous
*
Parenteral
*
Subcutaneous
Surgical Site Infections Molecule Type
Surgical Site Infections Products have been categorized under various Molecule types, such as
*
Antibody
*
Antisense oligonucleotides
*
Immunotherapy
*
Monoclonal antibody
*
Peptides
*
Protein
*
Recombinant protein
*
Small molecule
*
Stem Cell
*
Vaccine
Surgical Site Infections Pipeline Therapeutics Assessment
*
Surgical Site Infections Assessment by Product Type
*
Surgical Site Infections By Stage and Product Type
*
Surgical Site Infections Assessment by Route of Administration
*
Surgical Site Infections By Stage and Route of Administration
*
Surgical Site Infections Assessment by Molecule Type
*
Surgical Site Infections by Stage and Molecule Type
DelveInsight's Surgical Site Infections Report covers around 5+ products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further Surgical Site Infections product details are provided in the report. Download the Surgical Site Infections pipeline report to learn more about the emerging Surgical Site Infections therapies [https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the Surgical Site Infections Therapeutics Market include:
Key companies developing therapies for Surgical Site Infections are - Becton, Dickinson and Company, 3M Company, Biomerieux SA, Getinge Group, and Johnson & Johnson, and others.
Surgical Site Infections Pipeline Analysis:
The Surgical Site Infections pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of Surgical Site Infections with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Surgical Site Infections Treatment.
*
Surgical Site Infections key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
Surgical Site Infections Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Surgical Site Infections market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Surgical Site Infections drugs and therapies [https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Surgical Site Infections Pipeline Market Drivers
*
Rising number of surgeries and the growing geriatric population, increasing concern about hospital acquired infections along with rising incidences of hospital-acquired infections are some of the important factors that are fueling the Surgical Site Infections Market.
Surgical Site Infections Pipeline Market Barriers
*
However, lack of awareness regarding infection control measures, difficulty in identifying the site of infection and other factors are creating obstacles in the Surgical Site Infections Market growth.
Scope of Surgical Site Infections Pipeline Drug Insight
*
Coverage: Global
*
Key Surgical Site Infections Companies: Destiny Pharma plc, MinaPharm Pharma, Duke Clinical Research, Zurex Pharma, Inc., Merck Sharp & Dohme LLC, PolyPid Ltd., Durata Therapeutics, Lindenhofgruppe AG, Veristat, Inc, and others
*
Key Surgical Site Infections Therapies: Ciprodiazole, DFA-02, ZuraPrep, Ertapenem, XF-73, D-PLEX, Dalbavancin, BACTROBAN Registered Nasal ong, E-101, and others
*
Surgical Site Infections Therapeutic Assessment: Surgical Site Infections current marketed and Surgical Site Infections emerging therapies
*
Surgical Site Infections Market Dynamics: Surgical Site Infections market drivers and Surgical Site Infections market barriers
Request for Sample PDF Report for Surgical Site Infections Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Surgical Site Infections Report Introduction
2. Surgical Site Infections Executive Summary
3. Surgical Site Infections Overview
4. Surgical Site Infections- Analytical Perspective In-depth Commercial Assessment
5. Surgical Site Infections Pipeline Therapeutics
6. Surgical Site Infections Late Stage Products (Phase II/III)
7. Surgical Site Infections Mid Stage Products (Phase II)
8. Surgical Site Infections Early Stage Products (Phase I)
9. Surgical Site Infections Preclinical Stage Products
10. Surgical Site Infections Therapeutics Assessment
11. Surgical Site Infections Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Surgical Site Infections Key Companies
14. Surgical Site Infections Key Products
15. Surgical Site Infections Unmet Needs
16 . Surgical Site Infections Market Drivers and Barriers
17. Surgical Site Infections Future Perspectives and Conclusion
18. Surgical Site Infections Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=surgical-site-infections-pipeline-2025-comprehensive-clinical-trials-and-therapies-analysis-with-key-moa-and-roa-insights-by-delveinsight-destiny-pharma-plc-minapharm-pharma-duke-clinical-researc]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surgical Site Infections Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Destiny Pharma plc, MinaPharm Pharma, Duke Clinical Researc here
News-ID: 4185441 • Views: …
More Releases from ABNewswire
From Struggle to Strength: How Anthony Owens' Syrup Sandwiches is Empowering the …
In Syrup Sandwiches, Anthony Owens turns hardship into hope, showing how courage, resilience, and determination can transform even the toughest beginnings into a story of triumph.
Image: https://www.abnewswire.com/upload/2025/09/c7113a5d1752f9f484ea6540afa71e12.JPG
Anthony Owens is an award-winning author, speaker, and mentor whose life embodies resilience and triumph over adversity. Born in Dawson, Georgia, and raised in Brooklyn, New York, Owens grew up in challenging circumstances that later became the foundation for his inspiring literary voice. He…
Discount Printers Expands Authorized Dealer Network to Serve Growing Demand for …
Discount Printers strengthens its position as a leading supplier of both current and hard-to-find printer models through expanded manufacturer partnerships. The company's ability to source legacy equipment alongside competitive pricing on new models addresses critical gaps in the professional printing market.
The printing equipment market has evolved significantly in recent years, with many retailers focusing exclusively on current consumer models while abandoning support for the legacy and specialty equipment that remains…
Severe Asthma Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Severe Asthma Companies in the market include - Teva Pharmaceutical, AstraZeneca, Upstream Bio Inc., Oneness Biotech Co., Chia Tai Tianqing Pharmaceutical, Nantes University Hospital, Hamad Medical Corporation, Incyte Corporation, CSPC ZhongQi Pharmaceutical, AstraZeneca, Sunshine Guojian Pharmaceutical, Amgen, Areteia Therapeutics, Sanofi, GlaxoSmithKline, EMS, Advagene Biopharma Co., Teva Branded Pharmaceutical, and others.
DelveInsight's "Severe Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Severe Asthma, historical…
Home Coffee Brewers Embrace RetroRoast.co's Fresh Delivery Revolution and Commun …
RetroRoast.co transforms home coffee brewing through fresh, small-batch delivery service that doubles sales projections while building engaged online community. The startup's commitment to affordable, quality coffee challenges traditional assumptions about premium coffee accessibility for home consumers.
The home coffee brewing market has experienced significant transformation with the emergence of RetroRoast.co, a startup that addresses the fundamental challenge facing home coffee enthusiasts: accessing genuinely fresh, quality coffee at affordable prices. The company's…
More Releases for Surgical
Surgical Robotics Market to Witness Huge Growth by 2031 -Auris Surgical Robotics …
Surgical Robotics Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Surgical Robotics market emerge as the sector's next great thing? To discover the answer, look at the Surgical Robotics market analysis and projections. In-depth…
Surgical Laser Market - Shaping Surgical Precision: Surgical Laser, Guiding the …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Surgical Laser Market.
Surgical Laser Market: https://www.growthplusreports.com/report/surgical-laser-market/9172
The Surgical Laser Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Surgical Retractor Market - Enabling Surgical Mastery: Retractors for Uncompromi …
Newark, New Castle, USA: The "Surgical Retractor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Surgical Retractor Market: https://www.growthplusreports.com/report/surgical-retractor-market/7658
This latest report researches the industry structure, sales,…
Surgical Robots Market Hits USD 17,647.82 million by 2028 Lead By THINK Surgical …
There is a rise in the number of surgeries performed across the world. In the last 25 years, the incidence of cardiovascular diseases has increased globally. The rise in diabetic cases and lifestyle changes are leading to an increase in the number of cardiovascular surgeries and general surgeries. For instance, colorectal cancer is one of the most commonly found and lethal cancers developed in individuals due to the combined influence…
Surgical Robots Market Analysis 2020 - How COVID19 Impacting Surgical Robots Ind …
Report Analyzes Surgical Robots Market Size, Share and Industry Analysis By Type (Implantable Cardioverter Surgical Robots (ICD), Transvenous ICD, External Surgical Robots) By End User (Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Regional Forecast, 2019 - 2026.
Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/surgical-robots-market-100948
Key Players: Intuitive Surgical, Medtronic, Stryker, Smith & Nephew, Zimmer Biomet, TransEnterix Surgical, Inc Verb Surgical, THINK Surgical.
An…
Surgical Microscope Market Size, Surgical Microscope Market Share, Surgical Micr …
The global surgical microscope market was valued at USD 610.3 million in 2017 and is estimated to grow at a CAGR of 12.5% during the forecast period 2017-2026.
Request for Sample of This Research Report @ https://bit.ly/2xjcXML
Top Key Players:-
Carl Zeiss AG,
Leica Microsystems,
Takagi Corporation,
Seiler Precision Microscopes,
Topcon Corporation,
Alltion (Wuzhou) Co. Ltd.,
Alcon Laboratories, Inc.,
Haag-Streit Surgical,
Olympus Corporation,
Accu-scope, Inc.,
Novartis AG,
Danaher Corporation,
Labomed Microscopes,
Prescott’s Inc.,…
